Category Specific RSS

cancer diagnostics

CLEO meets with US FDA to develop strategy for ovarian cancer test launch

Ovarian cancer diagnostics company Cleo Diagnostics (ASX: COV) has taken a major step towards the US launch of its pre-surgical…

1 year ago

Rhythm Biosciences nears commercialisation of revolutionary cancer test following filing of approval documents with the TGA

Rhythm Biosciences (ASX: RHY) is a step closer to commercialising their bowel cancer detection test, having submitted documents to the…

3 years ago

Theranos, but make it legit.. Does this company have the answer to cancer detection via blood test?

Treating cancer is a primary goal of many biotech companies, but for any treatment to begin, physicians need a definitive…

3 years ago

Universal Biosensors partners with Peter Mac for handheld cancer diagnosis device

A handheld device which can remotely diagnose the presence of cancer cells is on the horizon with biotech company Universal…

4 years ago

How BCAL Diagnostics is improving minimally invasive methods of early cancer detection

With 1 in 7 Australian women diagnosed with breast cancer, the demand for a minimally invasive, accurate diagnostic test is…

4 years ago

Truscreen expands market for real time digital diagnostic testing device

Ahh the pap smear. The daunting, uncomfortable and downright annoying process of having a cervical swab taken to be tested…

4 years ago